Nitrocamptothecin in Treating Patients With Metastatic Melanoma

Clinical trial NCT00005875 · COMPLETED

Trial details

NCT number: NCT00005875
Sponsor: Astex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1999-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.